ClinicalTrials.Veeva

Menu

Ultrafiltration on Coagulation Function in Cardiac Surgery

K

Konkuk University Medical Center

Status

Enrolling

Conditions

Cardiac Valve Disease

Treatments

Procedure: Ultrafiltration

Study type

Interventional

Funder types

Other

Identifiers

NCT04031144
KUMC 2019-05-008

Details and patient eligibility

About

To determine the effect of modified ultrafiltration, which is usually employed for reducing free water at the end of cardiopulmonary bypass (CPB), on coagulation profile in patients undergoing cardiac surgery

Enrollment

28 estimated patients

Sex

All

Ages

19 months to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients undergoing elective cardiac surgery with cardiopulmonary bypass (CPB)
  • maximal clot formation (MCF) in ROTEM-EXTEM is reduced

Exclusion criteria

  • MCF > 50.5 mm before applying ultrafiltration
  • transfusion of packed RBC> 3 units during CPB
  • total ultrafiltration volume < 250 ml
  • hyperfibrinolysis (lysis% > 10%) before applying ultrafiltration

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

28 participants in 1 patient group

Ultrafiltration
Experimental group
Description:
Ultrafiltration is applied at the end of cardiopulmonary bypass. Maximal clot formation (MCF) of ROTEM-EXTEM tracing is reduced before applying the ultrafiltration.
Treatment:
Procedure: Ultrafiltration

Trial contacts and locations

1

Loading...

Central trial contact

Seong-Ho Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems